Literature DB >> 19012707

Malondialdehyde, nitric oxide and adrenomedullin levels in patients with primary dysmenorrhea.

Ebru Dikensoy1, Ozcan Balat, Sadrettin Pençe, Ayse Balat, Mustafa Cekmen, Muhuttin Yurekli.   

Abstract

AIM: The aim of the study was to examine whether there was a relationship between primary dysmenorrhea and serum levels of malondialdehyde (MDA), nitric oxide (NO) and adrenomedullin (AM) in young women.
METHODS: Sixty female subjects without serious medical problems, aged between 20 and 34, who had regular menses for at least six previous cycles, were involved. Blood samples were obtained from each patient on the first and the 21st days of her menstrual cycles. Pelvic examination and ultrasound were performed to determine any organic cause for dysmenorrhea in each patient. The subjects were divided into two groups. The study group consisted of 30 subjects with primary dysmenorrhea, and the control group consisted of 30 healthy subjects.
RESULTS: No statistically significant difference was observed in comparison of the following variables between the groups: age, parity and body mass index. The serum levels of MDA, NO, and AM were significantly higher on the first day compared to those on the 21(st) day in the study group (P < 0.05). The serum levels of MDA, NO, and AM were significantly higher in the study group compared to the control group both on the first and the 21st days of the menstrual cycles (P < 0.05).
CONCLUSION: In conclusion, the results of this study showed that the serum levels of MDA, NO, and AM increase in subjects with primary dysmenorrhea, suggesting the possibility that lipid peroxidation and oxidative stress play a significant role in the etiopathogenesis of primary dysmenorrhea.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012707     DOI: 10.1111/j.1447-0756.2008.00802.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  7 in total

1.  Procedural pain and oxidative stress in premature neonates.

Authors:  Laurel Slater; Yayesh Asmerom; Danilo S Boskovic; Khaled Bahjri; Megan S Plank; Katherine R Angeles; Raylene Phillips; Douglas Deming; Stephen Ashwal; Kristen Hougland; Elba Fayard; Danilyn M Angeles
Journal:  J Pain       Date:  2012-04-28       Impact factor: 5.820

2.  The Establishment of a Mouse Model of Recurrent Primary Dysmenorrhea.

Authors:  Fang Hong; Guiyan He; Manqi Zhang; Boyang Yu; Chengzhi Chai
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

3.  Investigation of oxidative balance in patients with dysmenorrhea by multiple serum markers.

Authors:  Nilgün Turhan; Havva Celik; Candan İltemir Duvan; Yüksel Onaran; Murat Aydın; Ferah Armutcu
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

Review 4.  A review of in vitro and in vivo studies on the efficacy of herbal medicines for primary dysmenorrhea.

Authors:  Kyoung-Sun Park; Kang-In Park; Deok-Sang Hwang; Jin-Moo Lee; Jun-Bock Jang; Chang-Hoon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-05       Impact factor: 2.629

5.  Lack of Adrenomedullin Aggravates Acute TNBS-Induced Colitis Symptoms in Mice, Especially in Females.

Authors:  Sonia Martínez-Herrero; Ignacio M Larrayoz; Judit Narro-Íñiguez; Susana Rubio-Mediavilla; Alfredo Martínez
Journal:  Front Physiol       Date:  2017-12-19       Impact factor: 4.566

6.  Frequency of Breakfast, Lunch, and Dinner and Incidence of Proteinuria: A Retrospective Cohort Study.

Authors:  Ryohei Tomi; Ryohei Yamamoto; Maki Shinzawa; Yoshiki Kimura; Yoshiyuki Fujii; Katsunori Aoki; Shingo Ozaki; Ryuichi Yoshimura; Manabu Taneike; Kaori Nakanishi; Makoto Nishida; Keiko Yamauchi-Takihara; Takashi Kudo; Yoshitaka Isaka; Toshiki Moriyama
Journal:  Nutrients       Date:  2020-11-19       Impact factor: 5.717

7.  Local Usage of Nigella sativa Oil as an Innovative Method to Attenuate Primary Dysmenorrhea: A Randomized Double-blind Clinical Trial.

Authors:  Ezat Samadipour; Mohammad Hassan Rakhshani; Akram Kooshki; Bahareh Amin
Journal:  Oman Med J       Date:  2020-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.